95264 ⎘
Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring-member bond
Benzopyrone estrogen receptor regulator
#302Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
#303Use of parthenolide derivatives as antileukemic and cytotoxic agents
#304Aryl hydrocarbon receptor (AhR) modifiers as novel cancer therapeutics
#305Lactam derivatives useful as orexin receptor antagonists
#306Polysubstituted benzofurans and medicinal applications thereof
#307Polymer-conjugated MetAP2 inhibitors, and therapeutic methods of use thereof
#308Substituted 1,3-Dioxanes and There Uses
#309Pyrrolidine derivatives
#310Piperidine derivatives
#311Compounds, pharmaceutical compositions and uses thereof
#312Preparation method of apigenin and dehydrosilybin mixture using radiation
#313TREATING VARIOUS DISORDERS USING TRKB AGONISTS
#314CONDENSED-CYCLIC COMPOUND, METHOD FOR PREPARING THE CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED-CYCLIC COMPOUND
#315SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS
#316Process for gamma-butyrolactone production
#317PROCESS FOR PREPARING DIVINYLARENE DIOXIDES
#318Substituted pyrrolotriazines as protein kinase inhibitors
#319Fumigillol type compounds and methods of making and using same
#320Synthesis of cleistanthin A and derivatives thereof
#321Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#322METHOD OF PREPARING DERIVATIVES/OLIGOMERS OF EPICATECHIN AND APPLICATIONS THEREOF
#323Benzocycloheptane and benzoxepine derivatives
#324Compounds, pharmaceutical compositions and uses thereof
#325Crystalline solids of a MetAP-2 inhibitor and methods of making and using same
#326Quinolone compound and pharmaceutical composition
#327Process for producing a monomer component from a genetically modified polyhydroxyalkanoate biomass
#328Four-ring compound having a plurality of CFO bonding groups, liquid crystal composition and liquid crystal display device
#329Treating various disorders using TrkB agonists
#330AROMATIC HETEROCYCLIC DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME
#3311,3-Dioxanes and Their Uses
#332Clerodane derivatives for modulation of leukotriene receptor activity and related diseases
#333Pharmaceutical compounds
#334BENZOFURAN DERIVATIVES
#335BENZOFURAN DERIVATIVES
#336Substituted acrylamide derivative and pharmaceutical composition comprising the same
#337Solid forms of gyrase inhibitor (R)-1-ethyl-3-[5-[2-(1-hydroxy-1-methyl-ethyl)pyrimidin-5-YL]-7-(tetrahydrofuran-2-yl)-1H-benzimidazol-2-YL]urea
#338SUBSTITUTED ENZOIMIDAZOLESULFONAMIDES AND SUBSTITUTED INDOLESULFONAMIDES AS MGLUR4 POTENTIATORS
#339Aminoquinazoline compounds for combating invertebrate pests
#340Chromene compound
#341Use of parthenolide derivatives as antileukemic and cytotoxic agents
#342Methods of making fused ring compounds
#343Tertiary alcohol derivative, polymer compound and photoresist composition
#344SUBSTITUTED 1,3-DIOXANES AND THEIR USES
#345Compounds having NPY Y5 receptor antagonistic activity
#346Indazole derivatives or pharmaceutically acceptable salts thereof as protein kinase inhibitors for proliferative diseases treatment, and a pharmaceutical composition containing the same as an active ingredient
#347Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
#348Process for preparing nebivolol
#349Amorphous silibinin for the treatment of viral hepatitis
#350VIRAL POLYMERASE INHIBITORS
#351Chemiluminescent compositions, methods, assays and kits for oxidative enzymes
#352Antiviral compounds and uses thereof
#353Cathepsin S inhibitor compounds
#354Macrocyclic compounds useful as inhibitors of kinases and HSP90
#355Unsaturated fatty acid monoesters and diesters on ascorbic acid and cosmetic uses thereof
#356Benzofuran derivatives
#357Sulfated C-glycoside, method for isolating same and method for synthesizing same
#358Herbicidally active cyclic diones and derivatives thereof, processes for their preparation, compositions, and method of controlling weeds
#359Salvinorin derivatives and uses thereof
#360PROCESS FOR PRODUCTION OF ORALLY INGESTIBLE COMPOSITION CONTAINING ARABINOFURANOSYL VITEXIN, AND USE OF THE COMPOSITION
#361Piperidinone derivatives as MDM2 inhibitors for the treatment of cancer
#362METHODS FOR SYNTHESIZING KOTALANOL AND STEREOISOMERS AND ANALOGUES THEREOF, AND NOVEL COMPOUNDS PRODUCED THEREBY
#363Method for preparing nebivolol
#364Composition of flavanolignan and amino acid with improved water solubility
#365BICYCLIC ACYLGUANIDINE DERIVATIVE
#366Compound having hydrocoumarin skeleton, liquid crystal compostition, and liquid crystal display device
#367Aminopyridine kinase inhibitors
#368Ether compounds with nitrogen-containing 5-member heterocycle and uses thereof
#369PPAR Modulators
#3705-QUINOLINONE AND IMIDAZOPYRIDINE COMPOUNDS AND USE THEREOF
#371Substituted naphthyridine compounds as inhibitors of Akt activity
#372Neurotrophic activity of deoxygedunin
#373PYRROLIDINE DERIVATIVES
#374Heteroaryl sulfonamides and CCR2/CCR9
#375Chromene modulators of chemokine receptor activity
#376NOVEL ESTROGEN RECEPTOR LIGANDS
#377Derivatives or dipyrannylidene type as anode interface layer in electronic devices
#378Transketalized compositions, synthesis, and applications
#379Pyridyl derivatives, their preparation and use
#380GLUCOKINASE ACTIVATORS
#3815-fluoropyrimidinone derivatives
#382Benzocycloheptane and benzoxepine derivatives
#383Iminipyridine derivatives and their uses as microbiocides
#384Compounds having NPY Y5 receptor antagonistic activity
#385Glucopyranoside derivatives
#386Process for preparing nebivolol
#387NEURONAL CELL DEATH INHIBITOR
#388p27 protein inducer
#3892-aryl and 2-heteroaryl 4H-1-benzopyran-4-one-6-amidino derivatives, new pharmacological agents for the treatment of arthritis, cancer and related pain
#390Chromene derivatives and use thereof as HIF hydroxylase activity inhibitors
#391Isobenzofuran analogs of sclerophytin A
#392Salvinorin Derivatives and Uses Thereof
#393ANTAGONISTS OF PGD2 RECEPTORS
#394HETEROCYCLIC ANTIVIRAL COMPOUNDS
#395AURONES AS SELECTIVE PDE INHIBITORS AND THEIR USE IN NEUROLOGICAL CONDITIONS AND DISORDERS
#396AURONES AS ESTROGEN RECEPTOR MODULATORS AND THEIR USE IN SEX HORMONE DEPENDENT DISEASES
#397Substituted piperazines
#398Benzofuran derivatives
#399Dioxaspiroketal derivatives, process for their preparation and uses thereof
#400Levulinic acid ester derivatives as reactive plasticizers and coalescent solvents
#4014-phenyl-pyrane-3,5-diones,4-phenyl-thiopyrane-3,6-diones and cyclohexanetriones as novel herbicides
#402Enantioselective reactions catalyzed by chiral triazolium salts
#403PIPERIDINE DERIVATIVES
#404Therapeutic compounds
#405Substituted heterocyclic compounds
#406GPR120 receptor agonists and uses thereof
#407Use of parthenolide derivatives as antileukemic and cytotoxic agents
#408Therapeutic compounds
#409Substituted 1,3-dioxanes useful as PPAR modulators
#410Pharmaceutical compounds
#411PYRIDAZINE DERIVATIVES
#412Triazole antifungal agents
#413Biaryl Sulfonamides and Methods for Using Same
#414Methods for the production of C-8 lactam lactone compounds
#415Quinolone compound and pharmaceutical composition
#416NOVEL PYRIDAZINE DERIVATIVES
#417Chroman compounds
#418Process for preparing Nebivolol
#419Process for preparing nebivolol
#420Ascorbic acid derivatives
#421Heteroaryl sulfonamides and CCR2
#422COMPOSITION FOR TREATMENT OF PANCREATIC CANCER
#423Thiosemicarbazones as anti-virals and immunopotentiators
#424BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND PROPHYLAXIS OF HEPATITIS C VIRAL INFECTIONS AND ASSOCIATED DISEASES
#425Therapeutic N-aryl or N-heteroaryl pyrazolidine and pyrazolidinone derivatives
#426Compound having hydrocoumarin skeleton, liquid crystal composition, and liquid crystal display device
#427Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#428INHIBITORS OF AKT ACTIVITY
#429Method for the Preparation of Escitalopram
#430TARGET MOLECULES OF PLADIENOLIDES, COMPOUNDS BINDING TO SUCH TARGET MOLECULES, AND SCREENING METHOD THEREOF
#431Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
#432N-(Hetero)Aryl Indole Derivatives as Pesticides
#433BENZOPYRANONE DERIVATIVES AND THEIR USE AS ANTI-VIRAL AGENTS
#434SUBSTITUTED HETEROCYCLIC COMPOUNDS
#435ELECTROLYTIC SOLUTION, SECONDARY BATTERY AND METHOD OF MANUFACTURING SAME, AND SULFONE COMPOUND
#436Method for the production of bisepoxides and dithiols
#437Substituted acrylamide derivative and pharmaceutical composition comprising the same
#438OPIOID RECEPTOR LIGANDS
#439Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#440Pyrrole derivative or salt thereof
#441PLANT-DERIVED THERAPEUTIC AGENT FOR MALIGNANT
#442Tertiary alcohol derivative, polymer compound and photoresist composition
#443Crosslinking agent, crosslinking method, method of controlling gene expression, and method of examining gene function
#444NEW EPOTHIOLONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR PHARMACEUTICAL USE
#445SUBSTITUTED HETEROCYCLIC COMPOUNDS
#446Agents for promoting the proliferation or differentiation of stem cells or neural progenitor cells
#447Isolation, Purification and Synthesis of Procyanidin B2 and Uses Thereof
#448Isolation, purification and synthesis of procyanidin B2 and uses thereof
#449Heterocyclic compounds as positive modulators of metabotropic glutamate receptor 2 (mGlu2 receptor)
#450Method for converting aloeresin A to aloesin
#451FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS
#452Composition, method of authenticating, methods of making authenticatable compositions, authenticatable articles made there from
#453PROCESS FOR THE PRODUCTION OF GLYCEROL ACETALS
#454Process To Obtain Synthetic And Semi-Synthetic Lignan Derivatives, Their Antiparasitic Activities And Corresponding Pharmaceutical Formulations, Including The Therapeutic Method Using Said Lignan For The Treatment Of Parasitosis
#455Pyran-dioxane derivatives, and the use thereof in liquid-crystalline media
#456Antiviral helioxanthin analogs
#457Inhibitors of Akt activity
#458Macrocyclic compounds useful as inhibitors of kinases and HSP90
#459Viral polymerase inhibitors
#460Chromone Derivatives Useful as Vanilloid Antagonists
#461Substituted pyrazoles, compositions containing such compounds and methods of use
#462Dihydropyrancarboxamides and uses thereof
#463Nebivolol and its pharmaceutically acceptable salts, process for preparation and pharmaceutical compositions of nebivolol
#464Compositions and methods of treatment using modulators of motoneuron diseases
#465Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis C viral infections and associated diseases
#466Salvinorin derivatives and uses thereof
#467Substituted hydantoins
#468GLUCOKINASE ACTIVATORS
#469Agents for imaging soluble a-beta
#470Carboxylic acid compounds
#471Benzo-fused 5-membered heterocyclic compounds, their production and use
#472Methods for imaging soluble A-beta
#473HIV INTEGRASE INHIBITORS
#474Pyrimidinone compounds useful as kinase inhibitors
#475Heteroaryl sulfonamides and CCR2
#476Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use
#477Dihydronaphthalene derivative compounds and agent comprising the derivative as active ingredient
#478Process for producing cyano substituted arene boranes and compounds
#479Dithiol compositions and methods of treating animal hides using the same
#480DNA-PK inhibitors
#481DNA-PK inhibitors
#482Process for production of 2,3,3′,4′-biphenyltetracarboxylic dianhydride
#483Viral polymerase inhibitors
#484Composition, method of authenticating, methods of making authenticatable compositions, authenticatable articles made there from
#485Spiro derivatives as lipoxygenase inhibitors
#486Preparation of 2′-fluoro-2′-alkyl-substituted or other optionally substituted ribofuranosyl pyrimidines and purines and their derivatives
#487Substituted piperazines
#488Method of using a cox-2 inhibitor and a topoisomerase II inhibitor as a combination therapy in the treatment of neoplasia
#489Agents with selective κ-opioid receptor affinity
#490Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines to block reuptake of norepinephrine, dopamine, and serotonin
#491Opioid receptor ligands and methods for their preparation
#492Salvinorin derivatives and uses thereof
#493Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
#494Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#495Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
#496Use of parthenolide derivatives as antileukemic and cytotoxic agents
#497Dihydrobenzofuranyl alkanamine derivatives and methods for using same
#498Pharmaceutical compounds
#499Production method of hexahydrofurofuranol derivative, intermediate therefor and production method thereof
#500Pyridone compounds as inhibitors of bacterial type III protein secreation systems
#501Novel analgesic and immunomodulatory cannabinoids
#502Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
#503Amines as histamine-3 receptor ligands and their therapeutic applications
#504Method for labeling with tritium
#505Substituted 4-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof
#506Benzopyran compounds useful for treating inflammatory conditions
#507Benzopyran compounds for use in the treatment and prevention of inflammation related conditions
#508Biaryl sulfonamides and methods for using same
#509Synthesis for the preparation of compounds for screening as potential tubulin binding agents
#510Thiosemicarbazones as anti-virals and immunopotentiators
#511Substituted benzopyran derivatives for the treatment of inflammation
#512Pyran compound or at least one derivative thereof
#513Salvinorin derivatives